C16 Biosciences snaps up $20m Series A
C16 Biosciences, a provider of sustainable alternatives to palm oil using biotechnology, has raised $20 million in Series A funding.
C16 Biosciences, a provider of sustainable alternatives to palm oil using biotechnology, has raised $20 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination